Targeting the eukaryotic translation initiation factor 4E to treat prostate cancer.

Furic, Luc (Primary Chief Investigator (PCI))
Risbridger, Gail (Chief Investigator (CI))

Anatomy & Developmental Biology

Project: Research

Status	Finished
Effective start/end date	1/01/11 → 31/03/16

Funding

Prostate Cancer Foundation of Australia: A$375,000.00

1 Article

Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity
Takizawa, I., Lawrence, M. G., Balanathan, P., Rebello, R., Pearson, H. B., Garg, E., Pedersen, J. S., Pouliot, N., Nadon, R., Watt, M. J., Taylor, R. A., Humbert, P. O., Topisirovic, I., Larsson, O., Risbridger, G. P. & Furic, L., 2015, In: Oncotarget. 6, 2, p. 604 - 616 13 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

30 Citations (Scopus)